News & Articles

Providing researchers with expanded capabilities in interrogating the tissue microenvironment

Join us on Tuesday, July 7, to discover how Aerospray technology can elevate your lab from acceptable to exceptional

The partnership aims to provide accessible solutions for labs involved in COVID-19 testing

Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients

First subjects recently administered immunizations in two studies of 20-valent pneumococcal conjugate vaccine candidate in infants; a pentavalent meningococcal vaccine candidate in adolescents; and a respiratory syncytial virus vaccine candidate in pregnant women

The partnership aims to accelerate the commercialization of enzymatic DNA synthesis

New research assesses the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin

Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019

Investment in state-of-the-art automation cements Abingdon Health’s position as a leading global rapid test manufacturer

Reliable, easy-to-use cryo-EM workflow solution promises to quadruple throughput for pharma labs

Our new expert webinar series aims to help you get the most from your microbiology research

The company is providing well-characterized and standardized human primary cells with matching specialty cell culture media

Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs

These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season

Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology

The RECOVERY trial has shown that the cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19

The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes